NuVasive, Inc. (NUVA) Tops Q2 EPS by 1c, Cuts FY11 EPS Gudiance & Reaffirms Sales
Tweet
Share
E-mailGet Alerts NUVA Hot Sheet
Price: $39.75 --0%
Financial Fact:
Total operating expenses: 159.29M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total operating expenses: 159.29M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
NuVasive, Inc. (NASDAQ: NUVA) reported Q2 EPS of $0.30, $0.01 better than the analyst estimate of $0.29. Revenue for the quarter came in at $133 million versus the consensus estimate of $132.04 million.
NuVasive, Inc. sees FY2011 EPS of $1.09-$1.12, versus prior guidance of $1.20-$1.23 and the consensus of $1.21. NuVasive, Inc. sees FY2011 revenue of $530-$540 million, versus the consensus of $535.4 million.
NuVasive, Inc. sees FY2011 EPS of $1.09-$1.12, versus prior guidance of $1.20-$1.23 and the consensus of $1.21. NuVasive, Inc. sees FY2011 revenue of $530-$540 million, versus the consensus of $535.4 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
